fda glp-1 news november 2025 updates bans compounded drugs glp-1 news 2025 november Shortage – Novo's Wegovy and Ozempic removed

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider

A Closer Look at the Research Two large-scale studies* examined the impact of GLP-1 drugs on a range of health conditions: Study 1 analyzed health records of over 200,000 individuals with type 2 diabetes who used GLP-1 drugs for four years

As a provider, if you can prescribe a single, once-a-week treatment that improves a patients metabolism, mental health, heart health, and blood pressure while reducing addictive drive and mortality, that is an extremely appealing option with high adherence potential

Store the reconstituted peptide at 2-8 degrees Celsius (standard refrigerator temperature)